Key facts
- Chinese researchers have developed a new method using microbubbles to treat aggressive liver tumours.
- The microbubbles are designed to deliver therapeutic agents directly to the tumour site.
- Preclinical studies showed significant shrinkage of liver tumours following the treatment.
- This approach aims to improve treatment effectiveness and reduce systemic side effects.
Chinese researchers have developed a novel method utilizing microbubbles to target and shrink aggressive liver tumours. This innovative approach involves injecting microbubbles that carry therapeutic agents directly to the cancerous cells. In preclinical studies, this targeted delivery system resulted in significant tumour shrinkage, indicating a promising new avenue for liver cancer treatment. The primary goal of this technique is to enhance the efficacy of cancer therapies while simultaneously minimizing the adverse side effects often associated with conventional treatments.